Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.
Press releases published on August 15, 2025
Southern Atlantic Healthcare Alliance (SAHA) Partners with RxParadigm to Launch Neutral 340B Claims Clearinghouse
EIN Presswire
·
August 15, 2025
CLAYMONT, DE, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- RxParadigm is pleased to announce a strategic partnership with Southern Atlantic Healthcare Alliance (SAHA), a leading regional hospital association, to offer a neutral 340B claims …
MOVE! App Enables Ground Reaction Force Estimation and Full 3D Biomechanical Analysis Using Only an iPhone
EIN Presswire
·
August 15, 2025
Developed by TNQ Tech, Co., the world’s first mobile app to provide lab-grade 3D motion tracking and ground reaction force estimation from video alone. NEWARK, DE, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- TNQ Tech Launches “MOVE!” — iPhone- …
rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares
GlobeNewswire
·
August 15, 2025
FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the closing of its initial public offering of 1,250,000 Japanese …
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
GlobeNewswire
·
August 15, 2025
Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company, today announced the …
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
GlobeNewswire
·
August 15, 2025
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic - Secured new service contract with EU biotech for …
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
GlobeNewswire
·
August 15, 2025
CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in the future of cancer therapy with their seamless, scalable and synergistic approach, today announced …
4DMT Announces New Employment Inducement Grants
GlobeNewswire
·
August 15, 2025
EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
GlobeNewswire
·
August 15, 2025
TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leader in senior care through the Program of All-inclusive Care for the Elderly (“PACE”), is proud to announce a new joint venture of its Tampa, Florida …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 15, 2025
BOSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on August 12, 2025, the company issued inducement awards …
Breeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma Limited
GlobeNewswire
·
August 15, 2025
Transaction Expected to Close in the Coming Days Combined Company to be Named YD Bio Limited and Expected to Trade on Nasdaq Under Ticker Symbol “YDES” IRVING, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Breeze Holdings Acquisition Corp. (“Breeze”) (OTCQX: …
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
GlobeNewswire
·
August 15, 2025
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya …
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
GlobeNewswire
·
August 15, 2025
Game changer for stroke, Alzheimer’s, and beyond Shifting from peripheral to tissue-specific oxygenation monitoring BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage …
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
GlobeNewswire
·
August 15, 2025
Palo Alto, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), appreciate the American Heart Association (AHA) and American College of Cardiology (ACC) for …
Appeal launched to support people impacted by Newfoundland fires
GlobeNewswire
·
August 15, 2025
OTTAWA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2025 Newfoundland …
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
GlobeNewswire
·
August 15, 2025
OTTAWA, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Feux de forêt de 2025 à Terre-Neuve-et-Labrador afin de venir en aide aux personnes et aux communautés éprouvées par les …
HeartSciences Announces Conference Participation and Investor Webinar
GlobeNewswire
·
August 15, 2025
Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 15, 2025
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
GlobeNewswire
·
August 15, 2025
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss …
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 15, 2025
– Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted …
Cingulate Provides Management Team Update
GlobeNewswire
·
August 15, 2025
Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced …